Cha Ki-chul is the Co-CEO and Chairman of InBody, as well as its founder. He manages the company alongside Co-CEO and President Lee Ra-mi.
Born on January 22, 1958, in Daejeon, Cha graduated from Daekwang High School and Yonsei University with a degree in mechanical engineering. He earned a master’s degree in mechanical engineering from KAIST and later pursued a PhD in biomedical engineering at the University of Utah during his studies in the U.S.
After completing a postdoctoral fellowship at Harvard Medical School, Cha returned to Korea and founded InBody (formerly Biospace) in 1996. Motivated by his desire to personally develop a body composition analyzer, he successfully created the 'InBody' device in 1997.
The device stands out for its use of multi-frequency measurement and direct segmental analysis, offering higher accuracy compared to existing products both domestically and internationally.
The popularity of the device even led to the creation of the neologism "to InBody," meaning to perform a body composition analysis.
Cha Ki-chul has expanded InBody’s product line beyond medical devices to include home-use and wearable devices, aiming to capture a larger share of the global health market.